None listed
Conditions
Interventions
Intervention1: iAttos ââ?¬â?? Ultra-diluted delta SARS-CoV-2 spike protein receptor binding domain ââ?¬â?? 6cH potency: Intervention is planned as administering the investigational medicinal product
Sponsors
Heritage Institute of Technology Kolkata
D N De Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 65 years 2. No major untreated diseases with apparently healthy status 3. No abnormality detected during clinical examination by experts and routine laboratory examinations (complete hemogram, fasting blood sugar, lipid profile, liver enzymes, urine for routine examination and microscopy, electrocardiogram, chest X-ray, ultrasonography of whole abdomen) 4. Literate patients; ability to read patient information sheet and voluntarily providing with written informed consent
Exclusion criteria
Exclusion criteria: 1. Vulnerable population ââ?¬â?? unconscious, ambulatory, too sick for consultation, differently abled, terminally or critically ill patients, mentally incompetent subjects 2. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure 3. Pregnant and puerperal women, lactating mothers 4. Tobacco chewing and/or smoking, alcoholism, and/or any other form(s) of substance abuse and/or dependence 5. Self-reported immune-compromised state (e.g., HIV)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interferon alpha, beta and gammaTimepoint: At baseline, after 48 and 72 hours, and after 7 days. The sequence will be repeated thrice after an intervening wash-out period of 7 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Interleukin 1Ã?², 6, 8, 10Timepoint: At baseline, after 48 and 72 hours, and after 7 days. The sequence will be repeated thrice after an intervening wash-out period of 7 days;Tumor growth factor Ã?²1, Ã?²3Timepoint: At baseline, after 48 and 72 hours, and after 7 days. The sequence will be repeated thrice after an intervening wash-out period of 7 days | — |
Countries
India
Contacts
Public ContactProf Dr Subhasish Ganguly
D. N. De Homoeopathic Medical College and Hospital
Outcome results
None listed